Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Pancreatic Cancer
Condition: Locally advanced (nonresectable Stage II or Stage III) or metastatic (Stage IV) adenocarcinoma of the pancreas
Dose: Intravenous infusion – 1000 mg/m²
Frequency: once weekly
Duration: 7 weeks; rest 1 week, then 1000 mg/m² intravenous on Days 1, 8, and 15 of each 28-day cycle
Note: Administer over 30 minutes. Various regimens exist including monotherapy and in combination with other chemotherapy agents (e.g., erlotinib, paclitaxel protein bound, capecitabine)
Indication: Non-small Cell Lung Cancer
Dose: Intravenous infusion – 1000 mg/m²
Frequency: on days 1, 8, and 15 of each 28-day cycle
Note: Administer over 30 minutes. Administer cisplatin 100 mg/m² intravenous after gemcitabine on day 1

Child Dose

Clinical InformationAdministration Information
Age: Pediatric
Dose: No approved pediatric dosage available
Note: No approved pediatric dosage available
Administration
  • For IV use only
  • Must be diluted properly
Side Effect

Drug Interaction

Drug NameRisk Factors
Warfarin
May increase the anticoagulant effect

Disease Interaction

Disease NameRisk Factors
Concurrent radical radiotherapy
Increased toxicity risk

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store at 25° C.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.